From the Departments of Medicine and Medical OncologyKaplan Cancer Center, New York University, New York; and Roswell Park Cancer Institute, Buffalo, NY; Department of Obstetrics and Gynecology, Louisiana State University Medical Center, New Orleans, LA; Division of Gynecologic Oncology, Indiana University Medical School, Indianapolis, IN; Department of Pathology, Columbus Cancer Council, James Cancer Hospital, Ohio State University, Columbus, OH; Section on Gynecologic Oncology, Wake Forest University...
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study”.
Patricia S. Braly, Mark F. Brady, Gregory Sutton, Theodore H. Niemann, Samuel L. Lentz +5 more